BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Reported: September 2, 2020 Initiated: August 10, 2020 #D-1542-2020
Product Description
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Reason for Recall
Failed Impurity /Degradation Specifications
Details
- Recalling Firm
- Par Pharmaceutical Inc.
- Units Affected
- 11,347 bottles
- Distribution
- Product was distributed to 9 major distributors throughout the United States.
- Location
- Chestnut Ridge, NY
Frequently Asked Questions
What product was recalled? ▼
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01. Recalled by Par Pharmaceutical Inc.. Units affected: 11,347 bottles.
Why was this product recalled? ▼
Failed Impurity /Degradation Specifications
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on September 2, 2020. Severity: Moderate. Recall number: D-1542-2020.
Related Recalls
FDA Drug Moderate
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…
Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…
Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical
Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
HANDELNINE GLOBAL LLC · 2026-02-11